All Stories

  1. WNT4 and WNT3A activate cell autonomous Wnt signaling independent of secretion

    Article • May 2018, Cold Spring Harbor Laboratory Press

    Dr. Matthew J Sikora

  2. CRISPR Fish Reel in Novel Roles for Estrogen Receptors in Reproduction

    Article • Endocrinology, July 2017, Endocrine Society

    Dr. Matthew J Sikora

  3. Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy

    Article • Endocrinology, December 2016, Endocrine Society

    Dr. Matthew J Sikora

  4. Endocrine Response Phenotypes Are Altered by Charcoal-Stripped Serum Variability

    Article • Endocrinology, October 2016, Endocrine Society

    Dr. Matthew J Sikora, Dr Adrian V Lee

  5. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines

    Article • September 2016, Springer Science + Business Media

    Dr. Matthew J Sikora

  6. High intra-tumoral stromal content defines Reactive breast cancer as a low-risk breast cancer subtype

    Article • Clinical Cancer Research, May 2016, American Association for Cancer Research (AACR)

    Dr. Matthew J Sikora

  7. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome

    Article • Gynecologic Oncology, May 2016, Elsevier

    Dr. Matthew J Sikora

  8. The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer

    Article • Breast Cancer Research and Treatment, April 2016, Springer Science + Business Media

    Dr. Matthew J Sikora

  9. Train the next generation of cancer scientists

    Article • October 2014, Experiment

    Dr. Matthew J Sikora

  10. Invasive Lobular Carcinoma Cell Lines Are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen Response

    Article • Cancer Research, January 2014, American Association for Cancer Research (AACR)

    Dr. Matthew J Sikora

  11. Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems

    Article • Steroids, June 2013, Elsevier

    Dr. Matthew J Sikora

  12. Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

    Article • Breast Cancer Research and Treatment, March 2012, Springer Science + Business Media

    Dr. Matthew J Sikora

  13. Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth

    Article • HIV Medicine, September 2010, Wiley

    Dr. Matthew J Sikora

  14. Reliable Gene Expression Measurements from Fine Needle Aspirates of Pancreatic Tumors

    Article • Journal of Molecular Diagnostics, September 2010, Elsevier

    Dr. Matthew J Sikora

  15. High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues

    Article • The Pharmacogenomics Journal, June 2010, Nature

    Dr. Matthew J Sikora

  16. Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

    Article • The Pharmacogenomics Journal, May 2009, Nature

    Dr. Matthew J Sikora

  17. Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

    Article • Breast Cancer Research and Treatment, January 2009, Springer Science + Business Media

    Dr. Matthew J Sikora

  18. The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6

    Article • Journal of Pharmacology and Experimental Therapeutics, August 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr. Matthew J Sikora

  19. The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance

    Article • Breast Cancer Research and Treatment, June 2008, Springer Science + Business Media

    Dr. Matthew J Sikora

  20. Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol

    Article • Cancer Biology & Therapy, May 2008, Taylor & Francis

    Dr. Matthew J Sikora